純5-HT6受體拮抗劑、乙醯膽鹼酯酶抑制劑和NMDA受體拮抗劑的三重組合

• 收藏
• 分享

专利权人:

SUVEN LIFE SCIENCES LIMITED

发明人:

NIROGI, Ramakrishna,SHINDE, Anil Karbhari,JAYARAJAN, Pradeep,BHYRAPUNENI, Gopinadh,KAMBHAMPATI, Ramasastri,JASTI, Venkateswarlu

申请号：

HK19100393

公开号：

HK1258022A1

申请日:

2019.01.10

申请国别(地区):

HK

年份:

2019

代理人:

摘要：

The present invention relates to a combination of pure 5-HT6 receptor antagonist, acetylcholinesterase inhibitor and NMDA receptor antagonist. Also, the present invention provides pure 5-HT6 receptor (5-HT6R) antagonists, or the pharmaceutically acceptable salt(s) thereof in combination with or as adjunct to acetylcholinesterase inhibitor and N-Methyl-D-aspartate (NMDA) receptor antagonist and their use in the treatment of cognitive disorders. The invention further provides the pharmaceutical composition containing the said combination.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/